Use the contingency table to answer the probability questions below. This table describes the results of 39,321 participants who were part of a study on the effectiveness in the Johnson & Johnson vaccine in preventing COVID-19. These patients received either the vaccine or placebo and were monitored for infection rates at 28 days after infection. Vaccine Placebo Developed COVID-19 182 541 No disease 19448 19150 If ONE study participant is randomly selected, what is the probability that... 1. They received a placebo? 2. They did NOT receive a placebo? 3. They developed COVID-19? 4. They developed COVID-19, given that they received the vaccine? 5. They developed COVID-19, given that they did NOT receive the vaccine? If TWO study participants are randomly selected WITHOUT REPLACEMENT, what is the probability that 6. They both developed COVID-19? If TWO study participants are randomly selected WITH REPLACEMENT, what is the probability that 7. They both had no disease